Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy
2014 Standout
Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis
2010
Iron deficiency: still under-diagnosed?
2015
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
1998 Standout
Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast
2004 StandoutNobel
A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
2011
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
2018 Standout
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
The multitude and diversity of environmental carcinogens
2007 StandoutNobel
Functional Gastroduodenal Disorders
2006 Standout
Primary central nervous system non-hodgkin's lymphoma: Survival advantages with combined initial therapy?
1995
Helicobacter pylori Infection and Iron Stores: A Systematic Review and Meta‐analysis
2008
Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias
1995
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
The prevalence of celiac disease in average-risk and at-risk Western European populations: A systematic review
2005
Efficacy of tailoredHelicobacter pylorieradication therapy based on antibiotic susceptibility andCYP2C19genotype
2014
Kyoto global consensus report onHelicobacter pylorigastritis
2015 Standout
The Oslo definitions for coeliac disease and related terms
2012 Standout
Lifestyle-related factors and environmental agents causing cancer: An overview
2007 StandoutNobel
Consequences of testing for celiac disease
2005
Dietary guidelines and implementation for celiac disease
2005
Effect ofMDR1C3435T polymorphism on cure rates ofHelicobacter pyloriinfection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation toCYP 2C19 genotypes and 23S rRNA genotypes ofH. pylori
2007
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
2017 Standout
American Gastroenterological Association (AGA) Institute Technical Review on the Diagnosis and Management of Celiac Disease
2006
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
2016 StandoutNobel
Effect of folic acid and vitamin C supplementation on folate status and homocysteine level: a randomised controlled trial in Italian smoker–blood donors
2002
Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling
2000 StandoutNobel
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
2013 Standout
Celiac Disease
2007 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Celiac disease in patients with an affected member, type 1 diabetes, iron-deficiency, or osteoporosis?
2005
Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia
2001
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*
2003 Standout
Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
2009 Standout
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
Long‐term follow‐up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection
2005
Systemic amyloidosis
2015 Standout
Coadaptation of Helicobacter pylori and humans: ancient history, modern implications
2009
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
H pylori antibiotic resistance: prevalence, importance, and advances in testing
2004 Standout
Personal Hair Dye Use and Cancer: A Systematic Literature Review and Evaluation of Exposure Assessment in Studies Published Since 1992
2006
Primary brain tumours in adults
2012 Standout
Immunoreactivity of MIC2 (CD99) in Acute Myelogenous Leukemia and Related Diseases
2000
Refractory Iron Deficiency Anemia as the Primary Clinical Manifestation of Celiac Disease
2003
Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report
2002
Annual Report to the Nation on the Status of Cancer (1973 Through 1998), Featuring Cancers With Recent Increasing Trends
2001
The influence of HLA‐matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA
1998
Pharmacogenomics-based Tailored Versus Standard Therapeutic Regimen for Eradication of H. pylori
2007
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet
2007
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Mitoxantrone
1996
Cancer Statistics, 2002
2002 Standout
Brain Tumors
2001 Standout
Iron Status and Helicobacter pylori Infection in Symptomatic Children: An International Multi-Centered Study
2013
The human microbiome: at the interface of health and disease
2012 Standout
A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease
2015 StandoutNobel
Guidelines for the management of iron deficiency anaemia
2011
Gluten Intolerance: Sex- and Age-Related Features
2006
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
2015 Standout
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Clinical Benefit of a Gluten-Free Diet in Type 1 Diabetic Children With Screening-Detected Celiac Disease
2006 StandoutNobel
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Acute Myeloid Leukemia
2015 Standout
Immune Modulation in Cancer with Antibodies
2013 StandoutNobel
Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)
1999
Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)
1999
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Current Trends in Diagnosis and Management of Cardiac Amyloidosis
2013
Polyphenol composition and in vitro antioxidant activity of amaranth, quinoa buckwheat and wheat as affected by sprouting and baking
2009 Standout
Mechanisms of Cancer Drug Resistance
2002 Standout
Iron deficiency anemia in Helicobacter pylori infection: meta-analysis of randomized controlled trials
2010
Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysis.
2010
Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity
2014
How I treat refractory and early relapsed acute myeloid leukemia
2015
Detection, evaluation, and management of iron-restricted erythropoiesis
2010
Iron-Deficiency Anemia
2015 Standout
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
2014 StandoutNobel
Integrating Genetic Approaches into the Discovery of Anticancer Drugs
1997 StandoutScienceNobel
Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome
2013
Immune Checkpoint Blockade in Cancer Therapy
2015 Standout
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
How I treat unexplained refractory iron deficiency anemia
2013
Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice
2011 StandoutNobel
Works of Bruno Monarca being referenced
Human herpes virus-6 seroprevalence and leukaemias: a case-control study
1999
Unawareness of gastrointestinal symptomatology in adult coeliac patients with unexplained iron‐deficiency anaemia presentation
2006
Red cell folate in elderly patients with myelodysplastic syndrome
1998
High Prevalence of Atrophic Body Gastritis in Patients With Unexplained Microcytic and Macrocytic Anemia
1999
Endoscopic Evaluation of the Upper Gastrointestinal Tract is Worthwhile in Premenopausal Women with Iron-Deficiency Anaemia Irrespective of Menstrual Flow
2003
Mitoxantrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemia.
1991
Gastrointestinal causes of refractory iron deficiency anemia in patients without gastrointestinal symptoms
2001
Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma
2008
Terminal transferase positive acute myeloid leukemia: Immunophenotypic characterization and response to induction therapy
1989
Efficacy of gluten-free diet alone on recovery from iron deficiency anemia in adult celiac patients
2001
Benefit of concomitant gastrointestinal and gynaecological evaluation in premenopausal women with iron deficiency anaemia
2008
Quick response to bortezomib plus dexamethasone in a patient with AL amyloidosis in first relapse
2011
Risk factors for essential thrombocythemia: A case-control study
1996
Fludarabine and prednisone in pretreated and refractory B-chronic lymphocytic leukemia (B-CLL) in advanced stages.
1993
Sequential combination of high dose ARA-C (HiDAC) and asparaginase (ASP) for the treatment of advanced acute leukemia and lymphoma
1984
Epidemiology of acute promyelocytic leukemia.
1996
Reversal of Iron Deficiency Anemia after Helicobacter pylori Eradication in Patients with Asymptomatic Gastritis
1999
Sequential combination of systemic high-dose ara-C and asparaginase for the treatment of central nervous system leukemia and lymphoma.
1984